Literature DB >> 16284379

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.

Jianfeng Xu1, James Lowey, Fredrik Wiklund, Jielin Sun, Fredrik Lindmark, Fang-Chi Hsu, Latchezar Dimitrov, Baoli Chang, Aubrey R Turner, Wennan Liu, Hans-Olov Adami, Edward Suh, Jason H Moore, S Lilly Zheng, William B Isaacs, Jeffrey M Trent, Henrik Grönberg.   

Abstract

It is widely hypothesized that the interactions of multiple genes influence individual risk to prostate cancer. However, current efforts at identifying prostate cancer risk genes primarily rely on single-gene approaches. In an attempt to fill this gap, we carried out a study to explore the joint effect of multiple genes in the inflammation pathway on prostate cancer risk. We studied 20 genes in the Toll-like receptor signaling pathway as well as several cytokines. For each of these genes, we selected and genotyped haplotype-tagging single nucleotide polymorphisms (SNP) among 1,383 cases and 780 controls from the CAPS (CAncer Prostate in Sweden) study population. A total of 57 SNPs were included in the final analysis. A data mining method, multifactor dimensionality reduction, was used to explore the interaction effects of SNPs on prostate cancer risk. Interaction effects were assessed for all possible n SNP combinations, where n = 2, 3, or 4. For each n SNP combination, the model providing lowest prediction error among 100 cross-validations was chosen. The statistical significance levels of the best models in each n SNP combination were determined using permutation tests. A four-SNP interaction (one SNP each from IL-10, IL-1RN, TIRAP, and TLR5) had the lowest prediction error (43.28%, P = 0.019). Our ability to analyze a large number of SNPs in a large sample size is one of the first efforts in exploring the effect of high-order gene-gene interactions on prostate cancer risk, and this is an important contribution to this new and quickly evolving field.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284379     DOI: 10.1158/1055-9965.EPI-05-0356

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  Machine learning for detecting gene-gene interactions: a review.

Authors:  Brett A McKinney; David M Reif; Marylyn D Ritchie; Jason H Moore
Journal:  Appl Bioinformatics       Date:  2006

2.  Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.

Authors:  Eleftherios Vairaktaris; Christos Yapijakis; Zoe Serefoglou; Dimitrios Avgoustidis; Elena Critselis; Sofia Spyridonidou; Antonis Vylliotis; Spyridoula Derka; Stavros Vassiliou; Emeka Nkenke; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-14       Impact factor: 4.553

3.  Exploring the performance of Multifactor Dimensionality Reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models.

Authors:  Todd L Edwards; Kenneth Lewis; Digna R Velez; Scott Dudek; Marylyn D Ritchie
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

4.  Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.

Authors:  Patricia Rodrigues; Jessica Furriol; Eduardo Tormo; Sandra Ballester; Ana Lluch; Pilar Eroles
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

5.  Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.

Authors:  Syed Rizwan Hussain; Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Hena Naqvi; Mohammad Waseem Ahmad; Saurabh Srivastava; Kumud Nigam; Shalini Gupta
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

6.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippmann; Howard L Parnes; Paul J Dluzniewski; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz
Journal:  Prostate       Date:  2015-06-05       Impact factor: 4.104

7.  A multifactorial analysis of obesity as CVD risk factor: use of neural network based methods in a nutrigenetics context.

Authors:  Ioannis K Valavanis; Stavroula G Mougiakakou; Keith A Grimaldi; Konstantina S Nikita
Journal:  BMC Bioinformatics       Date:  2010-09-08       Impact factor: 3.169

8.  Identification of viral infections in the prostate and evaluation of their association with cancer.

Authors:  Margarita L Martinez-Fierro; Robin J Leach; Lauro S Gomez-Guerra; Raquel Garza-Guajardo; Teresa Johnson-Pais; Joke Beuten; Idelma B Morales-Rodriguez; Mario A Hernandez-Ordoñez; German Calderon-Cardenas; Rocio Ortiz-Lopez; Ana M Rivas-Estilla; Jesus Ancer-Rodriguez; Augusto Rojas-Martinez
Journal:  BMC Cancer       Date:  2010-06-24       Impact factor: 4.430

9.  Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.

Authors:  E M Schaeffer; L Marchionni; Z Huang; B Simons; A Blackman; W Yu; G Parmigiani; D M Berman
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

10.  Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

Authors:  Ming-Hsi Wang; Kathy J Helzlsouer; Michael W Smith; Judith A Hoffman-Bolton; Sandra L Clipp; Viktoriya Grinberg; Angelo M De Marzo; William B Isaacs; Charles G Drake; Yin Yao Shugart; Elizabeth A Platz
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.